Urothelial Cancer
📧 Sign up to get email alerts when something new happens for Urothelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.
This clinical trial update reports on the outcomes, tolerability, and costs of using avelumab as maintenance therapy and pembrolizumab as se…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
This clinical trial is evaluating non-invasive assays for detecting urothelial cancer, with recruitment currently ongoing. The study is spon…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy
This clinical trial update reports results for avelumab in adults with advanced urothelial cancer after chemotherapy; the study has complete…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers [Phase 2]
Phase 2 clinical trial focusing on methods to characterize resistance to antibody-drug conjugates in solid tumors and to identify clinically…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma [Phase 2]
This is a Phase 2 clinical trial from Rutgers evaluating sequential gemcitabine and mitomycin for favorable high‑risk upper tract urothelial…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer [Phase 3]
A Phase 3 study evaluating nivolumab plus ipilimumab or standard-of-care chemotherapy versus standard-of-care chemotherapy alone in untreate…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Genotype-Phenotype Urothelial Cancer Registry
A genotype-phenotype urothelial cancer registry sponsored by Memorial Sloan Kettering Cancer Center; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients [Phase 1]
A Phase 1 clinical trial is investigating whether Vitamin B3 can enhance immunotherapy in patients with bladder cancer, with the study curre…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 3]
A Phase 3 study comparing sacituzumab govitecan versus physician's choice of treatment in locally advanced or metastatic unresectable urothe…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 dose-escalation and expansion study of XL495 in locally advanced or metastatic solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study assessing safety and tolerability of toripalimab in patients with advanced solid tumors, including melanoma and urothelial can…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations [Phase 3]
Phase 3 trial evaluating Erdafitinib versus standard therapies (vinflunine, docetaxel, or pembrolizumab) in advanced urothelial cancer with …
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Afatinib in Advanced Refractory Urothelial Cancer [Phase 2]
Phase 2 trial of afatinib in advanced refractory urothelial cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery [Phase 2]
Phase 2 trial evaluating safety and efficacy of pemigatinib in high-risk urothelial cancer after radical surgery has been terminated; result…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of Sacituzumab Govitecan in Japanese participants with advanced solid tumors is ongoing, including metastatic triple-negativ…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia
A real-world observational study of adults with metastatic urothelial cancer in South Korea and Saudi Arabia; the study status is completed.…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor
A recruiting clinical trial evaluating molecular markers from predicted DNA to assess clinical outcomes in patients with urothelial cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial of lurbinectedin as monotherapy in participants with advanced or metastatic solid tumors was terminated; results have been pos…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA) [Phase 1, Phase 2]
A Phase 1/2 clinical trial (NICARAGUA, NCT03425201) evaluating Niraparib in combination with Cabozantinib in advanced urothelial cancer has …
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors [Phase 1]
A Phase 1 pilot trial evaluating colchicine in urothelial cancer and other metastatic solid tumors has completed. The study, sponsored by Ic…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination [Phase 1]
Pfizer's Phase 1 study of PF-07329640, given alone or in combination, in advanced/metastatic solid tumors including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer [Phase 1]
Phase 1 study evaluating escalating doses of AGS-15ME as monotherapy in patients with metastatic urothelial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4 [Phase 1]
Phase 1 dose-escalation study of ASG-22CE as monotherapy in metastatic urothelial cancer and other nectin-4 expressing solid tumors has comp…